Stephen Witanowski
Internal Medicine · Baltimore, MDNPI 1003040726
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $789 and has fallen 97.6% since, to $19 in 2021.
Across 72 payments — averaging $14.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$221
- AstraZeneca$208
- Lilly USA, LLC$90
- Boehringer Ingelheim$77
- Amgen$76
- Johnson & Johnson$68
- plus $333 from 14 others
What the payments were for
- Food & beverage$1,073100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 18 | $221 |
| AstraZeneca | 15 | $208 |
| Lilly USA, LLC | 6 | $90 |
| Boehringer Ingelheim | 5 | $77 |
| Amgen | 4 | $76 |
| Johnson & Johnson | 4 | $68 |
| Amarin Pharma, Inc. | 3 | $60 |
| AbbVie | 3 | $50 |
| GSK | 2 | $29 |
| Arbor Pharmaceuticals, Inc. | 2 | $25 |
| Mannkind Corporation | 1 | $24 |
| Ultragenyx Pharmaceutical Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Pfizer | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $12 |
| Astellas Pharma US Inc | 1 | $12 |
How this compares
$1,073 in reported general payments places this provider in the 75th percentile of 2,979 internal medicine providers in Maryland.
Other internal medicine in Baltimore
- Param DedhiaBaltimore$636K
- Shawn DhillonBaltimore$227K
- Jeremy SugarmanBaltimore$210K
- Charles FlexnerBaltimore$133K
- Kristen MarroneBaltimore$97K
- Ana-Maria OrbaiBaltimore$89K
- Mark YarchoanBaltimore$89K
- David Muniz PedrogoBaltimore$82K
- Julie PaikBaltimore$76K
- Allison AgwuBaltimore$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.